Category: Vaccine Headlines

Hybrid immunity and strategies for COVID-19 vaccination

The Lancet Infectious Diseases – Since April, 2022, BA.2.12.1, BA.4, and BA.5 subvariants of the omicron (B.1.1.529) SARS-CoV-2 variant of concern have been spreading globally with increased viral fitness and transmissibility. Omicron BA.5 subvariant is currently the predominant COVID-19 threat worldwide. With the emergence of the antigenically distinct variants of concern, either natural immunity or […]

Sep 27, 2022

Moderna asks FDA to authorize omicron Covid boosters for children as young as 6 years old

CNBC – Moderna has asked the FDA to authorize omicron boosters for adolescents ages 12 to 17 and for kids ages 6 to 11. The Boston biotech company said it will ask the FDA to clear the omicron shots for the youngest children, 6 months through 6-years-old, later this year. The Centers for Disease Control […]

Sep 23, 2022

FDA Finds Flaws at Vaccine Factory, Accepts Moderna’s Assurances

Bloomberg – FDA inspectors found that particles in Moderna’s Covid-19 vaccine made by Catalent weren’t adequately looked into by the company. 

Sep 22, 2022

Updated COVID booster tied to strong Omicron immune response

CIDRAP – The new bivalent (two-strain) Moderna COVID-19 vaccine booster triggered stronger neutralizing antibody responses against the highly transmissible Omicron variant at 28 days than the previously authorized booster, with no safety concerns, according to the interim results of a phase 2/3 open-label, nonrandomized study published late last week in the New England Journal of Medicine.

Sep 22, 2022

When should I get the omicron booster?

Washington Post – The broad protection from these updated shots — called bivalent boosters — could prevent more than 100,000 hospitalizations in the coming months, according to one estimate. But many people still have questions about who should get the new booster, the best timing for the shot and if it would be better to delay […]

Sep 22, 2022

Moderna Booster Shots Are in Short Supply at US Pharmacies

Bloomberg – The US government supply of Moderna’s shot is currently limited, causing appointments for the product to vary across the country, a Walgreens Boots Alliance Inc. pharmacy spokesperson said in an emailed statement. CVS Health Corp. says some of its drugstores have used all of the updated shots they received from the US government, and the company is […]

Sep 22, 2022